FDA approval of a client’s small molecule drug product for i.v. injection Read More » August 3, 2021 ProJect Pharmaceutics receives CIR application (Research Tax Credit) for the benefit of its French customers Read More » July 30, 2021 Business Continuity Statement in the course of the global SARS-CoV-2 pandemic Read More » March 26, 2020 Meet ProJect Pharmaceutics at CPhI 2019 Read More » October 30, 2019 Join ProJect Pharmaceutics at Gene and Cell Therapy_Quality Developments to Commercialization Summit 2019 Read More » June 1, 2019 Meet ProJect Pharmaceutics at CPhI 2018 Read More » September 30, 2018 ProJect Pharmaceutics enters into collaboration with business partners in Asia Read More » July 1, 2018 Meet ProJect Pharmaceutics at BIO 2018 Read More » June 1, 2018 Formulation and lyophilization process development for live virus vaccines Read More » February 22, 2018 ProJect Pharmaceutics enters collaboration with German CMO as the preferred development partner for lyophilization Read More » September 19, 2017 Join ProJect Pharmaceutics at the upcoming World ADC Read More » January 30, 2017 High Protein Concentration Formulations Read More » October 29, 2015 Page1 Page2 Page3
ProJect Pharmaceutics receives CIR application (Research Tax Credit) for the benefit of its French customers Read More » July 30, 2021
Business Continuity Statement in the course of the global SARS-CoV-2 pandemic Read More » March 26, 2020
Join ProJect Pharmaceutics at Gene and Cell Therapy_Quality Developments to Commercialization Summit 2019 Read More » June 1, 2019
ProJect Pharmaceutics enters into collaboration with business partners in Asia Read More » July 1, 2018
Formulation and lyophilization process development for live virus vaccines Read More » February 22, 2018
ProJect Pharmaceutics enters collaboration with German CMO as the preferred development partner for lyophilization Read More » September 19, 2017
